Los Angeles Dodgers pitcher Jack Flaherty

...

Zach Pressnell

By Zach Pressnell

Contributing Sports Writer

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


Jack Flaherty is one of the bigger wild cards in free agency this winter. He's coming off an incredible season split between the Detroit Tigers and Los Angeles Dodgers, but he's still not valued as a true ace in free agency.

Still, there are plenty of teams interested in the right-hander this winter. His market includes a reunion with the Dodgers, where Flaherty has voiced his eagerness to return to.

The Boston Red Sox, Toronto Blue Jays, New York Yankees, and Tigers all make sense for the veteran righty.

Read More on MLB

ESPN insider Jeff Passan recently touched on Flaherty's free agency market, noting there's a new team in the mix.

Los Angeles Dodgers pitcher Jack Flaherty

...

"There's a chance Flaherty doesn't reach $100 million, but doing so is enough of a possibility to warrant his inclusion in this tier. He threw 162 innings in 2024, the most he had in five years, and booked a 5-to-1 strikeout-to-walk ratio," Passan wrote. "If the Washington Nationals decide to spend on an anchor for their rotation, Flaherty could make sense. And the Yankees -- who killed a deal for Flaherty at the trade deadline out of concerns about his back -- could be in again."

The Washington Nationals have emerged as a surprise suitor for Flaherty and it makes a ton of sense.

Washington has a young core of future stars that are finding their way in the big leagues. Adding Flaherty would give the Nats a bonafide ace that could anchor their rotation for cheaper than the top names on the market.

Last offseason, the Orioles added ace Corbin Burnes to anchor their roster of young stars. This offseason, the Nationals could follow that blueprint by signing Flaherty.

More MLB: Two 'Mystery Teams' Set To Join Yankees, Mets, Others In Juan Soto Sweepstakes

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines